Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under a share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity:
- Date of Purchase: May 27, 2025
- Shares Purchased: 805,127 ordinary shares
- Highest Price Paid: 419.10 pence per share
- Lowest Price Paid: 414.70 pence per share
- Volume Weighted Average Price: 416.58 pence per share
- Post-Transaction Share Capital: 9,007,726,680 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,003,646,475
Material Changes
The primary material change reported is the reduction of the company's share count through the cancellation of 805,127 shares purchased on May 27, 2025. This transaction updates the total number of ordinary shares with voting rights to 9,003,646,475.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, management commentary on operational performance, or discussion of risks and contingencies. It is a regulatory disclosure of a specific share transaction in compliance with the Market Abuse Regulation (Article 5(1)(b)).
Investor Verification Checklist
- Verify the total number of shares purchased under the Buyback Programme since its inception on March 28, 2025.
- Confirm the remaining authorization limit for the share buyback programme.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link.
- Check subsequent filings for updates on treasury share holdings and voting rights calculations.